This is the preview version of the Wisconsin State Legislature site.
Please see http://docs.legis.wisconsin.gov for the production version.
SWB:amn
2021 - 2022 LEGISLATURE
March 10, 2021 - Introduced by Senators Testin, Marklein, Darling and L. Taylor,
cosponsored by Representatives Novak, Tranel, Dittrich, Kitchens, Rozar,
Shankland, Skowronski, Spiros, Swearingen, Tauchen, Tusler, Vorpagel
and Subeck. Referred to Committee on Health.
SB194,1,3 1An Act to amend 253.13 (1); and to create 253.13 (1g) of the statutes; relating
2to:
newborn screening for Krabbe disease and requiring evaluation of
3additional lysosomal storage disorders for mandatory screening.
Analysis by the Legislative Reference Bureau
This bill requires that, in addition to the other congenital and metabolic
disorders for which testing is currently required under rules established by the
Department of Health Services, the attending physician, nurse-midwife, or in
certain circumstances, other birth attendant, must ensure that every infant born
undergoes testing for globoid cell leukodystrophy, also known as Krabbe disease,
which is a lysosomal storage disorder. Current law requires that an attending
physician or nurse-midwife ensure that every infant born undergoes testing for
certain congenital and metabolic disorders prior to the infant's discharge from the
hospital or maternity home. For infants born elsewhere, the attending physician,
nurse-midwife, or other birth attendant must ensure that the infant is tested within
a week of birth. As authorized by current law, DHS specifies by rule the congenital
and metabolic disorders for which newborn infants are to be screened. Current law
allows an exception to the testing requirement if the parents or legal guardian object
on the basis of a conflict with religious tenets and practices or with their personal
convictions.
Under the bill, for infants born in a hospital or maternity home, the attending
physician or nurse-midwife must ensure testing for Krabbe disease is completed
before the infant is discharged or within one week of birth, if the infant has not yet

been discharged. For births occurring outside a hospital or maternity home setting,
the attending physician, nurse-midwife, or other birth attendant must ensure
testing is done within one week of birth. The parental objection exemption under
current law also applies to the testing required under this bill.
The bill also requires DHS to evaluate on a biennial basis the appropriateness
of mandatory newborn testing for lysosomal storage disorders in addition to the
testing for Krabbe disease. If DHS determines that testing for one or more other
lysosomal storage disorders is appropriate, DHS may promulgate rules adding to the
list of disorders for which newborn testing is required.
For further information see the state fiscal estimate, which will be printed as
an appendix to this bill.
The people of the state of Wisconsin, represented in senate and assembly, do
enact as follows:
SB194,1 1Section 1 . 253.13 (1) of the statutes is amended to read:
SB194,2,82 253.13 (1) Tests; requirements. The attending physician or nurse licensed
3under s. 441.15 shall cause every infant born in each hospital or maternity home,
4prior to its the infant's discharge therefrom, to be subjected to tests for congenital and
5metabolic disorders, as specified in rules promulgated by the department. If the
6infant is born elsewhere than in a hospital or maternity home, the attending
7physician, nurse licensed under s. 441.15, or birth attendant who attended the birth
8shall cause the infant, within one week of birth, to be subjected to these tests.
SB194,2 9Section 2 . 253.13 (1g) of the statutes is created to read:
SB194,2,1510 253.13 (1g) Screening for certain lysosomal storage disorders. (a) In
11addition to the testing required under sub. (1), the attending physician or nurse
12licensed under s. 441.15 shall cause every infant born in each hospital or maternity
13home, prior to the infant's discharge or within one week of the birth if the infant has
14not yet been discharged, to be subjected to testing for globoid cell leukodystrophy,
15also known as Krabbe disease.
SB194,3,4
1(b) If the infant is born elsewhere than in a hospital or maternity home, the
2attending physician, nurse licensed under s. 441.15, or birth attendant who attended
3the birth shall cause the infant, within one week of birth, to be subjected to the
4testing under par. (a).
SB194,3,115 (c) No later than June 1, 2022, and every 2 years thereafter, the department
6shall evaluate the appropriateness of mandatory newborn testing for lysosomal
7storage disorders in addition to the testing required under par. (a). If the department
8determines that testing for one or more lysosomal storage disorders in addition to the
9testing required under par. (a) is appropriate, the department, under the authority
10granted under sub. (1), may promulgate rules adding to the list of disorders for which
11newborn testing is required.
SB194,3 12Section 3 . Effective date.
SB194,3,1413 (1) This act takes effect on the first day of the 3rd month beginning after
14publication.
SB194,3,1515 (End)
Loading...
Loading...